Filter Insights by:
CBAM is no longer just a reporting requirement; it is a measurable cost for every imported good
Watch a practical session exploring how the pharmaceutical industry can accelerate decarbonisation that matters most through innovative clean energy strategies.
Learn how 3Degrees helped a data centre operator navigate emerging regulatory environments and source biomethane.
Learn why pharma companies should rely on biomethane as a scalable, credible, and readily available low-carbon solution to address their scope 1 footprint.
To meet ambitious climate goals, businesses need to invest in high-quality carbon removals—before it's too late.
As businesses work to address residual emissions, biochar has emerged as a key CDR solution.
Get answers to common questions about biomethane and renewable natural gas (RNG), from how it is produced and what feedstocks are used, to how companies are using it to reduce scope 1 emissions and meet net-zero targets.
